Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

374 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TROG 18.01 phase III randomised clinical trial of the Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation: NINJA study protocol.
Martin J, Keall P, Siva S, Greer P, Christie D, Moore K, Dowling J, Pryor D, Chong P, McLeod N, Raman A, Lynam J, Smart J, Oldmeadow C, Tang CI, Murphy DG, Millar J, Tai KH, Holloway L, Reeves P, Hayden A, Lim T, Holt T, Sidhom M. Martin J, et al. Among authors: oldmeadow c. BMJ Open. 2019 Aug 20;9(8):e030731. doi: 10.1136/bmjopen-2019-030731. BMJ Open. 2019. PMID: 31434782 Free PMC article.
Assessing the impact of magnetic resonance treatment simulation (MRSIM) on target volume delineation and dose to organs at risk for oropharyngeal radiotherapy.
Richardson H, Kumar M, Tieu MT, Parker J, Dowling JA, Arm J, Best L, Greer PB, Clapham M, Oldmeadow C, O'Connor L, Wratten C. Richardson H, et al. Among authors: oldmeadow c. J Med Radiat Sci. 2022 Mar;69(1):66-74. doi: 10.1002/jmrs.552. Epub 2021 Oct 22. J Med Radiat Sci. 2022. PMID: 34676994 Free PMC article.
Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group).
Day F, Sridharan S, Lynam J, Gedye C, Johnson C, Fraser A, Thompson SR, Michael M, Leong T, Roy A, Kumar M, van der Westhuizen A, Quah GT, Mandaliya H, Mallesara G, Sappiatzer J, Oldmeadow C, Martin J. Day F, et al. Among authors: oldmeadow c. BMC Cancer. 2022 Dec 17;22(1):1324. doi: 10.1186/s12885-022-10407-8. BMC Cancer. 2022. PMID: 36528772 Free PMC article. Clinical Trial.
A Systematic Review of the Recent Consumption Levels of Sugar-Sweetened Beverages in Children and Adolescents From the World Health Organization Regions With High Dietary-Related Burden of Disease.
Ooi JY, Wolfenden L, Sutherland R, Nathan N, Oldmeadow C, Mclaughlin M, Barnes C, Hall A, Vanderlee L, Yoong SL. Ooi JY, et al. Among authors: oldmeadow c. Asia Pac J Public Health. 2022 Jan;34(1):11-24. doi: 10.1177/10105395211014642. Epub 2021 May 20. Asia Pac J Public Health. 2022. PMID: 34013784
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
Denham JW, Joseph D, Lamb DS, Spry NA, Duchesne G, Matthews J, Atkinson C, Tai KH, Christie D, Kenny L, Turner S, Gogna NK, Diamond T, Delahunt B, Oldmeadow C, Attia J, Steigler A. Denham JW, et al. Among authors: oldmeadow c. Lancet Oncol. 2019 Feb;20(2):267-281. doi: 10.1016/S1470-2045(18)30757-5. Epub 2018 Dec 19. Lancet Oncol. 2019. PMID: 30579763 Clinical Trial.
374 results